PhRMA brings in AstraZeneca VP for transition

WASHINGTON: PhRMA said that Chip Davis, VP of corporate external relations at AstraZeneca, would join the organization temporarily to guide the upcoming leadership transition at the pharmaceutical lobby.

WASHINGTON: PhRMA said that Chip Davis, VP of corporate external relations at AstraZeneca, would join the organization temporarily to guide the upcoming leadership transition at the pharmaceutical lobby.

Billy Tauzin, president and CEO, said he planned to resign in June from PhRMA. In addition, Mimi Simoneaux Kneuer, EVP of government and public affairs, announced April 5 that she would depart the organization. Davis will report to Tauzin.

"Chip will be assisting the search committee in finding a replacement for Billy," said Ken Johnson, SVP of communications and public affairs for PhRMA. "In that role, he certainly is going to take a look at everything we do here at PhRMA, from an advocacy standpoint as well as from a communications standpoint."

He starts at PhRMA on April 12 and will take a leave of absence from AstraZeneca. A company spokesperson said that his position will not be replaced. David Brennan, CEO of AstraZeneca and former chair of PhRMA, is head of the trade association's search committee.

At AstraZeneca, where he has worked since 2001, Davis is responsible for government relations, including strategic alliances and community relations. He is also the company's liaison to PhRMA. 

Johnson said that while the search committee is in the process of "identifying a list of extremely qualified candidates," the communications function is moving forward with its plans.

He noted that PhRMA will be announcing a new online and mobile program April 14, as part of the trade organization's five-year anniversary with the Partnership for Prescription Assistance. It will also announce a new spokesperson.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in